Gate Bioscience’s Post

Thoughts on this? >> After 14 years calling partnering shots at Genentech/Roche, James Sabry is headed back into the biotech fray >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #healthcare #pharmaceutical #pharma #biotech

At the BIO Investor Forum in SF today. Looking forward to connect with investors and strategic Pharma partners as we gear up to deliver on the next value inflections in our drug discovery journey

Thoughts on this? >> After 14 years calling partnering shots at Genentech/Roche, James Sabry is headed back into the biotech fray >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #pharma #biotech #healthcare

Financial Times's U.S. Pharma and Biotech Summit will take place in New York on May 16. Panel sessions will dive into funding pharma and biotech innovation, AI, pharma workforces and more. More details in this article from Pharmaceutical Executive: #pharma | #biotech | #innovation | #healthcare

Very comprehensive overview of investing in biotech and why this is a good time to be bullish on the industry. #biotechinnovation #investing

Join us for an insightful keynote interview with Christophe Weber, President & CEO of Takeda, at the Global Pharma and Biotech Summit on Nov 5. Learn about his vision for the future of biopharma and healthcare in Asia and beyond! Learn more: https://bit.ly/4fTMY22

🚀 Stay Ahead in the Biotech & Pharma World with BiopharmaWatch.com! 🧬💼 Are you tracking the latest catalysts and key dates in the biotech and pharmaceutical sectors? Look no further! BiopharmaWatch.com offers a comprehensive FDA/PDUFA Catalyst Calendar that keeps you informed about upcoming clinical trials, regulatory events, and other key updates that can impact stock movements. 📈 From phase 1 to phase 3 readouts, our platform provides a daily updated tool to help you make informed decisions and stay ahead of the market. Here is the list of companies for next two weeks: argenx SE, Adverum Biotechnologies, Inc., 4D Molecular Therapeutics, Inc., Biora Therapeutics, Inc., Aligos Therapeutics, Inc., Ocular Therapeutix, Inc., Annexon Biosciences, Inc., Phathom Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Jaguar Health, Inc., Cellectar Biosciences, Inc., Clearside Biomedical, Inc., Longeveron Inc., Acumen Pharmaceuticals, Inc. 🔍 Key Features: Real-time updates on clinical trials and FDA approvals Detailed insights into market capital and volume Easy-to-navigate interface to track event types and stages Check out the latest events for July and start leveraging this powerful tool for your investment strategies! Visit BiopharmaWatch.com today and never miss a critical update again! #Biotech #Pharma #Investment #FDA #ClinicalTrials #StockMarket #InvestmentStrategies

APC and VLE Therapeutics are thrilled to be shortlisted for 8 Pharma Industry Awards, including Pharma Company of the Year (SME), Biotech Company of the Year, and Sustainability Initiative of the Year. These nominations celebrate our team's hard work and dedication to delivering breakthrough medicines to patients at unprecedented speeds. Congratulations to all those nominated! #PharmaIndustryAwards #PharmaAwardsIRL #BiotechCompanyoftheYear #processdevelopment #processoptimization #BiotechCompanyoftheYear #processoptimization

How's #JPM2024 going? According to the smiles from KCR CEO, Mike Jagielski and CFO, Piotr Blonski, it's off to a great start! #KCRCRO #BostonBiotech #JPM #ClinicalDevelopment #ClinicalResearch #Healthcare #JPM24 #Conference #SanFrancisco

Enjoyed this conversation with Sonia Razzetti - for anyone thinking about moving into the start-up pharma & biotech world or recently made the move, this is worth a listen! Link to the main episode on the comments.